Rx only · Tablet, Extended Release · Oral

Amphetamine

Brands: Dyanavel Xr · Amphetamine

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US4 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)—

US makers1 labelers

Packages4

DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$13.065

Latest avg · Jul 22, 2026

-0%

Since Jan 1, 2026

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

20K

Rx · 2026 Q1

605K

Units dispensed

+6%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
NextWave Pharmaceuticals, Inc	unknown	4	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.